In A Nutshell The small, short trial showed no serious side effects, but much larger and longer studies are needed to prove ...

Until today, Haven-1 had a public launch date of mid-2026. However, as Haot explained in our interview, that launch date is ...

The Georgia General Assembly returned on Monday, January 12, 2026, for the first day of the 2026 legislative session and the ...

The rise of China, the buzz around AI, challenging global market dynamics, the recent surge in dealmaking and exciting new ...

In the days ahead, NASA could roll out the SLS rocket that will propel four astronauts on a journey around the moon. Here's the latest on Artemis 2.

An Israeli national was detained and questioned at a Canadian airport after a legal complaint filed by the Hind Rajab ...

A pair of NGO experts examine the effect of USAID's demise on NGOs, and what strategies they are using to stay afloat after ...

The Trump administration plans to halt billions of dollars in federal funding for social services programs in five states led ...

Initial AX-0810 data show no safety signals after 4 weeks of dosing and pharmacokinetics consistent with non-clinical data; Phase 1 enrollment and dosing in healthy volunteers ongoing with target ...

Plus: Public hearings on Trust Act to codify immigrant protections, creation of Viva White Oak development district ...

The McLean Citizens Association hosted a pre-legislative town hall on Jan. 6 at the McLean Community Center, bringing ...

The Cambridge, Massachusetts-based company – known as FogPharma until a rebrand in 2024 – needs cash for pivotal trials of ...